ABAT

The enzyme ABAT (4-aminobutyrate aminotransferase) plays pivotal roles in regulating the breakdown of gamma-aminobutyric acid (GABA), a crucial neurotransmitter in the central nervous system. 

ABAT, primarily expressed in the brain and liver, catalyzes the conversion of GABA into succinic semialdehyde, thus influencing neurotransmission and metabolic pathways. Alterations in the ABAT gene have been associated with various neurological disorders, shedding light on its significance in human health. 

Understanding the implications of ABAT gene variations has led to advancements in genetic testing methodologies aimed at unraveling its role in health and disease, offering promising avenues for personalized medicine interventions.

Understanding ABAT

Definition: What is ABAT? [1.]

ABAT, also known as 4-aminobutyrate aminotransferase, is an enzyme involved in the metabolism of gamma-aminobutyric acid (GABA), a neurotransmitter with inhibitory properties in the central nervous system.  ABAT is also known as GABA-Transaminase (GABA-T).  

By modulating GABA levels, ABAT influences inhibitory neurotransmission in the brain, contributing to the balance between excitation and inhibition.  [5.] 

Beyond its role in GABA metabolism, ABAT has been implicated in various physiological processes including energy metabolism, neurotransmission, and neurodevelopment. 

ABAT/GABA-T functions primarily in the brain and liver.  The active enzyme is complexed with pyridoxal-5-phosphate (PLP), the active form of vitamin B6.  ABAT functionality comes from PLP facilitating the transfer of amino groups between GABA and alpha-ketoglutarate, a key step in GABA metabolism.  [2., 3.]

The gene for ABAT may contain alterations or mutations that cause loss of function of the enzymes and can confer increased risk of disease in affected humans.  [3., 5., 6.]  Testing for genetic alterations in the form of SNPs is increasingly available and can shed light on an individual’s potential for health and disease.  

What is a SNP?

A SNP, or single nucleotide polymorphism, refers to a variation at a single position in a gene along its DNA sequence.  A gene encodes a protein, so an alteration in that gene programs the production of an altered protein.  As a type of protein with great functionality in human health, alterations in genes for enzymes may confer a difference in function of that enzyme.  The function of that enzyme may be increased or decreased, depending on the altered protein produced.  

SNPs are the most common type of genetic variation in humans and can occur throughout the genome, influencing traits, susceptibility to diseases, and response to medications.

The completion of the Human Genome Project has significantly expanded opportunities for genetic testing by providing a comprehensive map of the human genome that facilitates the identification of genetic variations associated with various health conditions, including identifying SNPs that may cause alterations in protein structure and function.  

Genetic testing for SNPs enables the identification of alterations in genes, shedding light on their implications in health and disease susceptibility.

Functions of ABAT

Alterations in ABAT enzyme function are increasingly associated with neurological disorders and metabolic syndromes.

Neurological Disorders

Emerging research suggests that alterations in ABAT levels or activity may be associated with neurological disorders such as epilepsy, autism spectrum disorder, and neurodegenerative diseases.  [4., 6.]

Mutations in the GABAT gene or alterations in ABAT activity may disrupt GABAergic neurotransmission, leading to imbalances in neuronal excitability and synaptic function. Consequently, aberrant ABAT function has been linked to seizure susceptibility, cognitive deficits, and neurodegeneration observed in these conditions.  [3.]

Metabolic Disorders

ABAT (GABA-T) alterations have also been linked to mitochondrial dysfunction.  Because of its high activity in the brain, phenotypic changes in metabolic function are understood to primarily impact energy metabolism and oxidative stress pathways in the nervous system, which are implicated in various neurological disorders. 

Understanding the relationship between ABAT/GABA-T alterations and mitochondrial health provides crucial insights into the pathogenesis of these conditions and may inform the development of novel therapeutic strategies targeting mitochondrial function.  [3.]

Prognostic Value of ABAT

Genetic mutations of ABAT/GABA-T are extremely rare, but identifying these individuals may provide early intervention.  [3.] 

Lab Testing for AARS

Genetic testing for single nucleotide polymorphisms (SNPs) typically involves obtaining a sample of DNA which can be extracted from blood, saliva, or cheek swabs. 

The sample may be taken in a lab, in the case of a blood sample.  Alternatively, a saliva or cheek swab sample may be taken from the comfort of home. 

Test Preparation

Prior to undergoing genetic testing, it's important to consult with a healthcare provider or genetic counselor to understand the purpose, potential outcomes, and implications of the test. This consultation may involve discussing medical history, family history, and any specific concerns or questions. 

Additionally, individuals may be advised to refrain from eating, drinking, or chewing gum for a short period before providing a sample to ensure the accuracy of the test results. Following sample collection, the DNA is processed in a laboratory where it undergoes analysis to identify specific genetic variations or SNPs. 

Once the testing is complete, individuals will typically receive their results along with interpretation and recommendations from a healthcare professional. 

It's crucial to approach genetic testing with proper understanding and consideration of its implications for one's health and well-being.

Patient-Centric Approaches

A patient-centered approach to SNP genetic testing emphasizes individualized medicine, tailoring healthcare decisions and interventions based on an individual's unique genetic makeup.

When that is combined with the individual’s health status and health history, preferences, and values, a truly individualized plan for care is possible. 

By integrating SNP testing into clinical practice, healthcare providers can offer personalized risk assessment, disease prevention strategies, and treatment plans that optimize patient outcomes and well-being. 

Genetic testing empowers a deeper understanding of genetic factors contributing to disease susceptibility, drug response variability, and overall health, empowering patients to actively participate in their care decisions. 

Furthermore, individualized medicine recognizes the importance of considering socioeconomic, cultural, and environmental factors alongside genetic information to deliver holistic and culturally sensitive care that aligns with patients' goals and preferences. 

Through collaborative decision-making and shared decision-making processes, patients and providers can make informed choices about SNP testing, treatment options, and lifestyle modifications, promoting patient autonomy, engagement, and satisfaction in their healthcare journey.

Order Genetic Testing

Click here to compare genetic test panels and order genetic testing for health-related SNPs.